⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for Open Vs Robotic-Assisted Radical Cystectomy: A Randomized Trial

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Open Vs Robotic-Assisted Radical Cystectomy: A Randomized Trial

Official Title: Open Vs Robotic-Assisted Radical Cystectomy: A Randomized Trial

Study ID: NCT01157676

Study Description

Brief Summary: This is a multi-institutional, randomized trial evaluating oncologic, perioperative, and functional outcomes following two standard care procedures for radical cystectomy. The participants will have one of the standard care procedures as part of their care. The two procedures that will be followed are open radical cystectomy and robotic assisted radical cystectomy (RARC). Open cystectomy is considered to be the more traditional approach. While newer, RARC is considered to be equivalent to open surgery when it is performed by a trained robotics surgeon. The reported complication rates of RARC appear comparable to open surgery. This means there is no significant difference in the risk between the two standard procedures. However, despite these potential advantages, true comparison between the open and robotic technique with regards to long term cancer related and functional outcomes has not been accomplished because previous studies did not compare patients of equal health status. The researchers hope to learn whether or not patients undergoing RARC recover more quickly than or at the same rate as patients undergoing an open radical cystectomy while having non inferior cancer related outcomes. This study is funded by the National Institutes of Health (NIH).

Detailed Description:

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

Mayo Clinic Arizona, Phoenix, Arizona, United States

University of California, Irvine Medical Center (UC Irvine), Orange, California, United States

Stanford University, Stanford, California, United States

University of Miami, Miami, Florida, United States

University of Chicago Medical Center, Chicago, Illinois, United States

Loyola University Medical Center, Maywood, Illinois, United States

Brigham and Women's Hospital, Boston, Massachusetts, United States

University of Michigan Health System, Ann Arbor, Michigan, United States

University of Minnesota, Minneapolis, Minnesota, United States

Mayo Clinic, Rochester, Minnesota, United States

University of North Carolina, Chapel Hill, North Carolina, United States

Ohio State University Medical Center, Columbus, Ohio, United States

Vanderbilt University Medical Center, Nashville, Tennessee, United States

The University of Texas Health Science Center at San Antonio, Medical Arts & Research Center, San Antonio, Texas, United States

University of Virginia Health Science Center, Department of Urology, Charlottesville, Virginia, United States

Cancer Research and Biostatistics (Data Management and Statistical Office), Seattle, Washington, United States

Contact Details

Name: Dipen J Parekh, MD

Affiliation: University of Miami

Role: PRINCIPAL_INVESTIGATOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: